IMMUNOTREX Trademark

Trademark Overview


On Friday, May 5, 2023, a trademark application was filed for IMMUNOTREX with the United States Patent and Trademark Office. The USPTO has given the IMMUNOTREX trademark a serial number of 97923157. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 9, 2024. This trademark is owned by IUVENTIS TECHNOLOGIES, INC.. The IMMUNOTREX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research services; Consulting services in the field of pharmaceutical research; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
immunotrex

General Information


Serial Number97923157
Word MarkIMMUNOTREX
Filing DateFriday, May 5, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Description of MarkThe mark consists of the letters "IMMUNOTRE" in a blue sans serif font, with a line running through those letters, a blue letter "X" stylized as a chromosome pair and a circle representing the centromere of the chromosome, any white within and outside the blue letters and chromosome is background only and not claimed as a feature of the mark.
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical research services; Consulting services in the field of pharmaceutical research; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 5, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIUVENTIS TECHNOLOGIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNORTH ANDOVER, MA 01845

Party NameIUVENTIS TECHNOLOGIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNORTH ANDOVER, MA 01845

Trademark Events


Event DateEvent Description
Tuesday, May 9, 2023NEW APPLICATION ENTERED
Thursday, May 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 6, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 31, 2024ASSIGNED TO EXAMINER
Wednesday, January 31, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 31, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, January 31, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 31, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, January 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 9, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 9, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED